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Figure: Expression of IGF1R (A), IRS1 (B), IGFBP1 (C), IGFBP3 (D), IGFBP5 (E)
and IGFBP6 (F) in preserved and degenerated areas of human OA cartilage.
Results of qPCR analysis coupled with laser capture microdissection.
Pres, preserved area; Deg, degenerated area. **p< 0.01 against preserved
areas.
Results: Using microarray data, expression of possible anabolic factors
for chondrocytes (growth factors and anabolic cytokines) and related
molecules (receptors, antagonists and molecules related to signal
transduction) was compared between the degenerated areas and
preserved areas. This comparison revealed that the expression of IGF1R
and IRS1 could be reduced, and the expression of IGF-BP1, 3, 5 and 6
could be increased in degenerated areas. These ﬁndings were conﬁrmed
by qPCR analysis combined with LCM (Figure). The reduction in IGF1R
and IRS1 and the increase in IGF-BP3 and 5 in degenerated areas
were conﬁrmed by immunohistochemistry and protein quantiﬁcation
by BioPlex. These results indicated that the reduced response to IGFs
could account for the decline in cartilage matrix gene expression in
degenerated areas.
Next, cartilage explants were prepared from degenerated and preserved
areas, respectively, and treated with speciﬁc inhibitors for Akt signaling,
the dominant signal pathway activated by IGFs. This treatment reduced
the expression of type II collagen and aggrecan only in the explants
from preserved areas, but such a reduction was not observed in those
from degenerated areas, suggesting that Akt signaling had been already
attenuated in vivo in the degenerated areas.
In a variety of cells, expression of IGF1R and IRS1 is regulated by Sp1.
Thus, we investigated Sp1 expression within OA cartilage, and found that
its expression was obviously reduced in degenerated areas. We also found
that the expression levels of IGF1R and IRS1 were signiﬁcantly correlated
with that of Sp1 within human OA cartilage. Thus, in the degenerated
areas of OA cartilage, the expression of IGF1R and IRS1was considered
to be attenuated by the reduction in Sp1 expression. To conﬁrm this,
the expression of Sp1 in primary cultured human chondrocytes was
suppressed by RNAi or elevated by adenoviral transduction, which
indeed caused the increase or reduction of IGF1R and IRS1 expression,
respectively.
Conclusions: The result of this study has shown that the response of
chondrocytes to IGFs might be reduced in the degenerated areas of OA
cartilage. Since OA synovial ﬂuid contains substantial amounts of IGF-1,
reduced response to IGFs may well account for the decline in cartilage
matrix expression in degenerated areas within OA cartilage.
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Purpose: Age is the most prominent predisposition for development
of osteoarthritis (OA), a slowly progressive joint disease characterized
by gradual loss of articular cartilage. Age-related changes of articular
cartilage are likely to play a role. Advanced glycation endproducts (AGEs)
accumulate in the cartilage matrix with increasing age and adversely
affect the biomechanical properties of the cartilage matrix and inﬂuences
chondrocyte activity. These effects render the tissue more prone to
damage and may potentially lead to the development of OA. In clinical
studies AGEing of cartilage and its relation to actual cartilage damage
can only be measured by surrogate markers (e.g. serum, skin or urine
AGE levels and imaging or biochemical markers of cartilage damage).
Relations between AGEing and cartilage damage are found although
results are far from conclusive, maybe due to the limited relation
between cartilage AGE levels and AGE levels of surrogate compartments
or surrogate markers of cartilage damage. Thus far, a direct comparison
between cartilage AGE level and actual cartilage damage has not been
made. Therefore, the present study compares actual cartilage AGE levels
(in addition to urinary AGE levels) in OA directly with actual cartilage
damage by use of macroscopic, histological and biochemical analyses.
Methods: Cartilage from the femoral condyles of 69 knee OA patients
(average age: 68.8±9.0 years; 50/19 female/male ratio) undergoing
total knee replacement and urine samples were obtained and analysed
for pentosidine as marker of AGE. Cartilage damage was evaluated
by macroscopic, histological, and biochemical analyses (proteoglycan
turnover).
Results: Cartilage and urine pentosidine both increased with increasing
age (R =0.493 and R=0.535 resp. both with p =0.000) as previously found.
The higher the macroscopic cartilage damage the lower the cartilage
pentosidine amount (R = −0.286, p = 0.028). This inverse relation was also
found when related to the histological cartilage damage (R = −0.428,
p = 0.001). The biochemical analysis of cartilage damage corroborated
this as the different proteoglycan parameters also demonstrated an
inverse relation with cartilage pentosidine levels (PG content R =0.179,
p=NS; %PG synthesis R = 0.443, p = 0.000; % total PG released R=−0.392,
p = 0.002; and % newly formed GAG released R=−0.400, p = 0.002). Four
urine pentosidine similar results were found (R =0.057, ns; PG synthesis
rate: R = 0.279, p = 0.032; total PG release: R = −0.288, p = 0.027; newly
formed GAG release: R = −0.248, ns). In multiple regression analysis this
relationship seems to be independent of age. For cartilage histology, PG
synthesis, % total PG and newly formed GAG released as independent
variable and age as well as cartilage pentosidine as dependent variable in
most cases the explained variance was around 40% (R2 ≈0.4). The partial
regression coefﬁcient (B) was not signiﬁcant for age, but in all cases it
was for cartilage pentosidine.
Conclusions: There is an inverse relation between cartilage AGEs and
actual cartilage damage measured on different levels in end stage OA
using the cartilage tissue itself. This is contrasting the existing literature,
which show positive relations making use of indirect measurements. This
difference might be explained by the fact that in case of more severe
OA, the cartilage can contain lower amount of pentosidine due to newly
formed collagen not yet modiﬁed by the non-enzymatic glycation. What
the exact contribution of AGEs to OA progression is remains ambiguous.
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Background: Joint diseases such as osteoarthritis (OA) result in
destruction of articular cartilage. Transforming Growth factor beta is
considered as a protective factor in young cartilage while this function is
lost upon aging. In chondrocytes, TGF beta can signal via phosphorylation
of SMAD2/3 (via ALK5) or SMAD1/5/8 (via ALK1). In earlier studies
we have found that in young healthy human cartilage (age < 10 years)
only SMAD2/3 phosphorylation (SMAD2/3P) occurs and no SMAD1/5/8
phosphorylation (SMAD1/5/8P). Moreover, in human OA cartilage we
showed a signiﬁcant correlation between ALK1 and MMP13 expression.
Purpose: To study the expression of SMAD2/3P and SMAD1/5/8P in
chondrocyte populations in end-stage human OA cartilage and whether
addition of exogenous TGF beta modulates the expression of MMP13,
ALK5 and ALK1 in this cartilage.
Methods: Human OA articular cartilage was obtained during knee joint
replacement (n =20). Cartilage sections were stained for SMAD2/3P and
SMAD1/5/8P using speciﬁc antibodies. In addition, human OA cartilage
was incubated with 10ng/ml TGF beta for 24h. Part of the cartilage
